Pardoprunox T1769
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pardoprunox is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties. Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
CAS nr:
269718-84-5
Purity:
98%
Molecular Weight:
233,27
SMILES:
CN1CCN(CC1)c1cccc2c1oc(=O)[nH]2
Formula:
C12H15N3O2
Pathway:
GPCR/G Protein,Neuroscience,GPCR/G Protein,Neuroscience,Neuroscience,GPCR/G Protein
Target:
5-HT Receptor,5-HT Receptor,Dopamine Receptor,Dopamine Receptor,Adrenergic Receptor,Adrenergic Receptor
